
Jaguar Health fell 99.3% from $59.50 to $0.40, behind the S&P 500's +12.7%. Its worst day was Sep 23 (−74.1%), and its low came Sep 15 at $0.22.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-3297.00 missed the $-2236.50 estimate on $3.1M revenue (est. $4.2M).
+1.4% · S&P 500 −0.9%
EPS of $-189.00 beat the $-1071.00 estimate on $3.4M revenue (est. $4.2M).
Story events cover the past 12 months · Times ET
−0.1% · S&P 500 0.0%
EPS of $-204.00 beat the $-1071.00 estimate on $20.3M revenue (est. $3.7M).
−5.4% · S&P 500 +0.2%
EPS of $-235.50 was reported on $1.2M revenue.
−5.4% · S&P 500 +0.2%
Jaguar Health closed at its lowest level of the year, 99.6% below where the year started.
−29.6% · S&P 500 −0.5%
Where it ended: a close of $0.40 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 24, 2026.
Nothing in the past 12 months.
All JAGX analyst actionsNothing in the past 12 months.
All JAGX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for JAGX and SPY from Benzinga historical bars. Not investment advice.